Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for Melanoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for Melanoma
Authors
Keywords
-
Journal
Nanomaterials
Volume 10, Issue 1, Pages 161
Publisher
MDPI AG
Online
2020-01-17
DOI
10.3390/nano10010161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanomaterial Applications in Photothermal Therapy for Cancer
- (2019) Austin Doughty et al. Materials
- An artificial antigen-presenting cell delivering 11 immune molecules expands tumor antigen-specific CTLs in ex vivo and in vivo murine melanoma models
- (2019) Lei Zhang et al. Cancer Immunology Research
- Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
- (2019) Tessa Knox et al. Scientific Reports
- Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling
- (2019) Koen A. Marijt et al. Journal for ImmunoTherapy of Cancer
- Nanoemulsion Structural Design in Co-Encapsulation of Hybrid Multifunctional Agents: Influence of the Smart PLGA Polymers on the Nanosystem-Enhanced Delivery and Electro-Photodynamic Treatment
- (2019) Urszula Bazylińska et al. Pharmaceutics
- Apatinib-loaded nanoparticles inhibit tumor growth and angiogenesis in a model of melanoma
- (2019) Ju Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Customizing poly(lactic- co -glycolic acid) particles for biomedical applications
- (2018) Edyta Swider et al. Acta Biomaterialia
- HDAC6 interacts with PTPN1 to enhance melanoma cells progression
- (2018) Jiaqi Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Photothermal Therapy Generates a Thermal Window of Immunogenic Cell Death in Neuroblastoma
- (2018) Elizabeth E. Sweeney et al. Small
- Protein corona: a new approach for nanomedicine design
- (2017) Van Hong Nguyen et al. International Journal of Nanomedicine
- Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models
- (2017) Jing Tian et al. Journal of Materials Chemistry B
- Epigenetic Therapeutics: A New Weapon in the War Against Cancer
- (2016) Nita Ahuja et al. Annual Review of Medicine
- Nanoemulsion-templated polylelectrolyte multifunctional nanocapsules for DNA entrapment and bioimaging
- (2016) Urszula Bazylińska et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Essential role of HDAC6 in the regulation of PD-L1 in melanoma
- (2016) M. Lienlaf et al. Molecular Oncology
- Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
- (2016) Qian Chen et al. Nature Communications
- Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
- (2015) K.V. Woan et al. Molecular Oncology
- Single-Step Assembly of DOX/ICG Loaded Lipid–Polymer Nanoparticles for Highly Effective Chemo-photothermal Combination Therapy
- (2013) Mingbin Zheng et al. ACS Nano
- Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells
- (2013) Joel C. Sunshine et al. BIOMATERIALS
- Quantitative Detection of PLGA Nanoparticle Degradation in Tissues following Intravenous Administration
- (2013) Abdul Khader Mohammad et al. MOLECULAR PHARMACEUTICS
- Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer
- (2013) Adham S. Bear et al. PLoS One
- Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer
- (2012) Sanjay I. Thamake et al. BIOMATERIALS
- BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy
- (2012) Richard C. Koya et al. CANCER RESEARCH
- Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
- (2012) Berkley E Gryder et al. Future Medicinal Chemistry
- Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer
- (2012) Missak Haigentz et al. ORAL ONCOLOGY
- Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery
- (2011) Zhiping Zhang et al. BIOMATERIALS
- A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
- (2011) John D. Hainsworth et al. CANCER INVESTIGATION
- Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA
- (2011) GS Vinod Kumar et al. International Journal of Nanomedicine
- Coformulation of Doxorubicin and Curcumin in Poly(d,l-lactide-co-glycolide) Nanoparticles Suppresses the Development of Multidrug Resistance in K562 Cells
- (2011) Ranjita Misra et al. MOLECULAR PHARMACEUTICS
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents
- (2010) M. Namdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biocompatibility and drug delivery systems
- (2010) Daniel S. Kohane et al. Chemical Science
- Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions
- (2009) Faiyaz Shakeel et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Costimulatory and coinhibitory receptors in anti-tumor immunity
- (2009) Gregory Driessens et al. IMMUNOLOGICAL REVIEWS
- A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
- (2008) T. H. Luu et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started